Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
26 hedge funds and large institutions have $775K invested in Renalytix plc American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
78% less capital invested
Capital invested by funds: $3.46M → $775K (-$2.69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$331K |
| 2 |
PA
Pinnacle Associates
New York
|
+$71.2K |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$68.5K |
| 4 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$35.8K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$22.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$655K |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$542K |
| 3 |
Lazard Asset Management
New York
|
-$74.4K |
| 4 |
HF
HRT Financial
New York
|
-$26K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Lazard Asset Management
New York
| – | -$74.4K | -124,797 | -99% |
|
|
HF
27
HRT Financial
New York
| – | -$26K | -31,523 | Closed |
|
|
XT
28
XTX Topco
George Town,
Cayman Islands
| – | -$20.4K | -24,588 | Closed |
|
29
Millennium Management
New York
| – | -$11.5K | -13,883 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | -$151 | -175 | Closed |
|
|
PA
31
Parallel Advisors
San Francisco,
California
| – | -$52 | -60 | Closed |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$26 | -44 | -69% |
|
RNLX Hedge Fund Activity: Q2 2024 in Review
26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q2 2024, worth a combined $775K — down 78% from $3.46M a quarter earlier.
Fund positioning in RNLX was balanced in Q2 2024: 7 funds opened new positions, 7 closed out, 5 added to existing stakes and 6 trimmed.
The largest buyer was Levin Capital Strategies, opening a new position worth an estimated $331K. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $655K sold.
- 26 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $775K of Renalytix plc American Depositary Shares stock for Q2 2024, down 78% quarter-over-quarter.
- 7 funds opened new Renalytix plc American Depositary Shares positions in Q2 2024 and 7 closed out, a net change of 0 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q2 2024 was Levin Capital Strategies, an estimated $331K added.
- The largest Renalytix plc American Depositary Shares seller in Q2 2024 was Gilder Gagnon Howe & Co, an estimated $655K sold.
Based on aggregated 13F filings for Q2 2024.